{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T04:13:29Z","timestamp":1744258409473,"version":"3.40.4"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T00:00:00Z","timestamp":1615161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T00:00:00Z","timestamp":1615161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s11845-021-02576-5","type":"journal-article","created":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T08:02:52Z","timestamp":1615190572000},"page":"337-346","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Minding metabolism: targeted interventions to improve cardio-metabolic monitoring across early and chronic psychosis"],"prefix":"10.1007","volume":"191","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9545-0615","authenticated-orcid":false,"given":"John R.","family":"Kelly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyola","family":"Gounden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aoibheann","family":"McLoughlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Legris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Therese","family":"O\u2019Carroll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roisin","family":"McCafferty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liliana","family":"Marques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maeve","family":"Haran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Farrelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Loughrey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gr\u00e1inne","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiden","family":"Corvin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7694-0283","authenticated-orcid":false,"given":"Catherine","family":"Dolan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,8]]},"reference":[{"issue":"1","key":"2576_CR1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/wps.20614","volume":"18","author":"D Vancampfort","year":"2019","unstructured":"Vancampfort D et al (2019) The impact of pharmacological and non-pharmacological interventions to improve physical health outcomes in people with schizophrenia: a meta-review of meta-analyses of randomized controlled trials. World Psychiatry 18(1):53\u201366","journal-title":"World Psychiatry"},{"key":"2576_CR2","doi-asserted-by":"crossref","unstructured":"Pearce M et al (2020) Evaluation of an exercise physiology service in a youth mental health service. Ir J Psychol Med p. 1-6","DOI":"10.1017\/ipm.2020.91"},{"issue":"1","key":"2576_CR3","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1471-244X-11-104","volume":"11","author":"K Buhagiar","year":"2011","unstructured":"Buhagiar K, Parsonage L, Osborn DPJ (2011) Physical health behaviours and health locus of control in people with schizophrenia-spectrum disorder and bipolar disorder: a cross-sectional comparative study with people with non-psychotic mental illness. BMC Psychiatry 11(1):104","journal-title":"BMC Psychiatry"},{"key":"2576_CR4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.genhosppsych.2018.03.002","volume":"54","author":"A Waugh","year":"2018","unstructured":"Waugh A et al (2018) A feasibility study of a physiotherapy-led motivational programme to increase physical activity and improve cardiometabolic risk in people with major mental illness. Gen Hosp Psychiatry 54:37\u201344","journal-title":"Gen Hosp Psychiatry"},{"issue":"3","key":"2576_CR5","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1447-0349.2012.00816.x","volume":"21","author":"B Happell","year":"2012","unstructured":"Happell B, Davies C, Scott D (2012) Health behaviour interventions to improve physical health in individuals diagnosed with a mental illness: A systematic review. Int J Ment Health Nurs 21(3):236\u2013247","journal-title":"International Journal of Mental Health Nursing"},{"key":"2576_CR6","doi-asserted-by":"crossref","unstructured":"Green CA et al (2015) The STRIDE weight loss and lifestyle intervention for individuals taking antipsychotic medications: a randomized trial. Am J Psychiatry\u00a0\u00a0172(1): p. 71-81","DOI":"10.1176\/appi.ajp.2014.14020173"},{"key":"2576_CR7","doi-asserted-by":"crossref","unstructured":"De Hert M et al (2011)\u00a0Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry\u00a010(1): p. 52-77.","DOI":"10.1002\/j.2051-5545.2011.tb00014.x"},{"issue":"6","key":"2576_CR8","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1192\/bjp.bp.110.085100","volume":"199","author":"K Wahlbeck","year":"2011","unstructured":"Wahlbeck K et al (2011) Outcomes of Nordic mental health systems: life expectancy of patients with mental disorders. Br J Psychiatry 199(6):453\u2013458","journal-title":"British Journal of Psychiatry"},{"issue":"10","key":"2576_CR9","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1001\/archpsyc.64.10.1123","volume":"64","author":"S Saha","year":"2007","unstructured":"Saha S, Chant D, McGrath J (2007) A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry 64(10):1123\u20131131","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"2576_CR10","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/wps.20802","volume":"19","author":"O Plana-Ripoll","year":"2020","unstructured":"Plana-Ripoll O et al (2020) Nature and prevalence of combinations of mental disorders and their association with excess mortality in a population-based cohort study. World Psychiatry 19(3):339\u2013349","journal-title":"World Psychiatry"},{"issue":"3","key":"2576_CR11","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1176\/appi.ajp.2012.12050599","volume":"170","author":"C Crump","year":"2013","unstructured":"Crump C et al (2013) Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study. Am J Psychiatry 170(3):324\u201333","journal-title":"Am J Psychiatry"},{"issue":"1","key":"2576_CR12","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-clinpsy-032813-153657","volume":"10","author":"TM Laursen","year":"2014","unstructured":"Laursen TM, Nordentoft M, Mortensen PB (2014) Excess early mortality in schizophrenia. Annu Rev Clin Psychol 10(1):425\u2013448","journal-title":"Annual Review of Clinical Psychology"},{"issue":"1","key":"2576_CR13","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/wps.20384","volume":"16","author":"NH Liu","year":"2017","unstructured":"Liu NH et al (2017) Excess mortality in persons with severe mental disorders: a multilevel intervention framework and priorities for clinical practice, policy and research agendas. World Psychiatry\u202f: Official J World Psychiatr Assoc (WPA) 16(1):30\u201340","journal-title":"World psychiatry : official journal of the World Psychiatric Association (WPA)"},{"issue":"12","key":"2576_CR14","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1001\/jamapsychiatry.2015.1737","volume":"72","author":"M Olfson","year":"2015","unstructured":"Olfson M et al (2015) Premature mortality among adults with schizophrenia in the United States. JAMA Psychiatry 72(12):1172\u201381","journal-title":"JAMA Psychiatry"},{"issue":"8","key":"2576_CR15","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S2215-0366(19)30132-4","volume":"6","author":"J Firth","year":"2019","unstructured":"Firth J et al (2019) The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness. Lancet Psychiatry 6(8):675\u2013712","journal-title":"Lancet Psychiatry"},{"issue":"6","key":"2576_CR16","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.ahj.2005.02.007","volume":"150","author":"CH Hennekens","year":"2005","unstructured":"Hennekens CH et al (2005) Schizophrenia and increased risks of cardiovascular disease. Am Heart J 150(6):1115\u201321","journal-title":"Am Heart J"},{"key":"2576_CR17","doi-asserted-by":"crossref","unstructured":"Wang Q, Xu R, Volkow ND (2020)\u00a0Increased risk of COVID-19 infection and mortality in people with mental disorders: analysis from electronic health records in the United States. World Psychiatry\u00a020(1):124\u2013130","DOI":"10.1002\/wps.20806"},{"key":"2576_CR18","doi-asserted-by":"crossref","first-page":"100057","DOI":"10.1016\/j.metop.2020.100057","volume":"8","author":"S Ghoneim","year":"2020","unstructured":"Ghoneim S et al (2020) The incidence of COVID-19 in patients with metabolic syndrome and non-alcoholic steatohepatitis: a population-based study. Metabolism Open 8:100057","journal-title":"Metabolism Open"},{"key":"2576_CR19","doi-asserted-by":"crossref","unstructured":"Bansal R, Gubbi S, Muniyappa R (2020) Metabolic syndrome and COVID 19: endocrine-immune-vascular interactions shapes clinical course. Endocrinology\u00a0161(10)","DOI":"10.1210\/endocr\/bqaa112"},{"issue":"7821","key":"2576_CR20","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","volume":"584","author":"EJ Williamson","year":"2020","unstructured":"Williamson EJ et al (2020) Factors associated with COVID-19-related death using OpenSAFELY. Nature 584(7821):430\u2013436","journal-title":"Nature"},{"key":"2576_CR21","doi-asserted-by":"crossref","unstructured":"Anderson MR, Geleris J, Anderson DR, Zucker J, Nobel YR, Freedberg D, Small-Saunders J, Rajagopalan KN, Greendyk R, Chae SR, Natarajan K, Roh D, Edwin E, Gallagher D, Podolanczuk A, Barr RG, Ferrante AW, & Baldwin MR (2020) Body mass index and risk for intubation or death in SARS-CoV-2 infection: a retrospective cohort study. Ann Intern Med 173:782-790","DOI":"10.7326\/M20-3214"},{"issue":"2","key":"2576_CR22","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/schbul\/sbs082","volume":"39","author":"AJ Mitchell","year":"2013","unstructured":"Mitchell AJ et al (2013) Is the prevalence of metabolic syndrome and metabolic abnormalities increased in early schizophrenia? A comparative meta-analysis of first episode, untreated and treated patients. Schizophr Bull 39(2):295\u2013305","journal-title":"Schizophr Bull"},{"issue":"2","key":"2576_CR23","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/schbul\/sbr148","volume":"39","author":"AJ Mitchell","year":"2013","unstructured":"Mitchell AJ et al (2013) Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders\u2013a systematic review and meta-analysis. Schizophr Bull 39(2):306\u201318","journal-title":"Schizophr Bull"},{"key":"2576_CR24","first-page":"534","volume":"183","author":"RG McCreadie","year":"2003","unstructured":"McCreadie RG (2003) Diet, smoking and cardiovascular risk in people with schizophrenia: descriptive study. Br J Psychiatry 183:534\u20139","journal-title":"Br J Psychiatry"},{"key":"2576_CR25","doi-asserted-by":"crossref","unstructured":"J\u00f8rgensen M et al\u00a0(2018)\u00a0Quality and predictors of diabetes care among patients with schizophrenia: a Danish nationwide study. Psychiatr Serv\u00a069(2): p. 179-185","DOI":"10.1176\/appi.ps.201600460"},{"issue":"1","key":"2576_CR26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.schres.2006.06.026","volume":"86","author":"HA Nasrallah","year":"2006","unstructured":"Nasrallah HA et al (2006) Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline. Schizophr Res 86(1):15\u201322","journal-title":"Schizophrenia Research"},{"issue":"8","key":"2576_CR27","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1017\/S003329171300216X","volume":"44","author":"TM Laursen","year":"2014","unstructured":"Laursen TM et al (2014) Cardiovascular drug use and mortality in patients with schizophrenia or bipolar disorder: a Danish population-based study. Psychol Med 44(8):1625\u201337","journal-title":"Psychol Med"},{"issue":"1","key":"2576_CR28","doi-asserted-by":"crossref","first-page":"e55176","DOI":"10.1371\/journal.pone.0055176","volume":"8","author":"M Nordentoft","year":"2013","unstructured":"Nordentoft M et al (2013) Excess mortality, causes of death and life expectancy in 270,770 patients with recent onset of mental disorders in Denmark, Finland and Sweden. PLoS One 8(1):e55176","journal-title":"PLoS One"},{"key":"2576_CR29","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.schres.2019.10.061","volume":"216","author":"P Kugathasan","year":"2020","unstructured":"Kugathasan P et al (2020) Association of physical health multimorbidity with mortality in people with schizophrenia spectrum disorders: using a novel semantic search system that captures physical diseases in electronic patient records. Schizophr Res 216:408\u2013415","journal-title":"Schizophrenia Research"},{"issue":"1","key":"2576_CR30","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12916-016-0734-z","volume":"14","author":"B Stubbs","year":"2016","unstructured":"Stubbs B et al (2016) Physical multimorbidity and psychosis: comprehensive cross sectional analysis including 242,952 people across 48 low- and middle-income countries. BMC Med 14(1):189","journal-title":"BMC Medicine"},{"key":"2576_CR31","doi-asserted-by":"crossref","unstructured":"Lydon A et al (2020) Routine screening and rates of metabolic syndrome in patients treated with clozapine and long-acting injectable antipsychotic medications: a cross-sectional study. Ir J Psychol Med\u00a0p. 1-9","DOI":"10.1017\/ipm.2020.12"},{"issue":"2","key":"2576_CR32","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/acps.12439","volume":"132","author":"B Stubbs","year":"2015","unstructured":"Stubbs B et al (2015) The prevalence and predictors of type two diabetes mellitus in people with schizophrenia: a systematic review and comparative meta-analysis. Acta Psychiatr Scand 132(2):144\u2013157","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"2","key":"2576_CR33","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.schres.2005.02.010","volume":"76","author":"J de Leon","year":"2005","unstructured":"de Leon J, Diaz FJ (2005) A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res 76(2):135\u2013157","journal-title":"Schizophrenia Research"},{"issue":"2","key":"2576_CR34","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jpsychires.2012.10.005","volume":"47","author":"S Dipasquale","year":"2013","unstructured":"Dipasquale S et al (2013) The dietary pattern of patients with schizophrenia: a systematic review. J Psychiatr Res 47(2):197\u2013207","journal-title":"Journal of Psychiatric Research"},{"key":"2576_CR35","unstructured":"Kelly JR et al (2020) The role of the gut microbiome in the development of schizophrenia. Schizophr Res"},{"issue":"3","key":"2576_CR36","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/wps.20458","volume":"16","author":"D Vancampfort","year":"2017","unstructured":"Vancampfort D et al (2017) Sedentary behavior and physical activity levels in people with schizophrenia, bipolar disorder and major depressive disorder: a global systematic review and meta-analysis. World Psychiatry 16(3):308\u2013315","journal-title":"World Psychiatry"},{"issue":"2","key":"2576_CR37","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.schres.2016.01.010","volume":"170","author":"R Carney","year":"2016","unstructured":"Carney R et al (2016) Cardiometabolic risk factors in young people at ultra-high risk for psychosis: a systematic review and meta-analysis. Schizophr Res 170(2):290\u2013300","journal-title":"Schizophrenia Research"},{"issue":"6","key":"2576_CR38","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1192\/bjp.2019.159","volume":"215","author":"F Gaughran","year":"2019","unstructured":"Gaughran F et al (2019) Effect of lifestyle, medication and ethnicity on cardiometabolic risk in the year following the first episode of psychosis: prospective cohort study. Br J Psychiatry 215(6):712\u2013719","journal-title":"British Journal of Psychiatry"},{"issue":"3","key":"2576_CR39","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/jamapsychiatry.2016.3803","volume":"74","author":"T Pillinger","year":"2017","unstructured":"Pillinger T et al (2017) Impaired glucose homeostasis in first-episode schizophrenia: a systematic review and meta-analysis. JAMA Psychiatry 74(3):261\u2013269","journal-title":"JAMA psychiatry"},{"issue":"11","key":"2576_CR40","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S2215-0366(16)30262-0","volume":"3","author":"BI Perry","year":"2016","unstructured":"Perry BI et al (2016) The association between first-episode psychosis and abnormal glycaemic control: systematic review and meta-analysis. Lancet Psychiatry 3(11):1049\u20131058","journal-title":"The Lancet Psychiatry"},{"issue":"6","key":"2576_CR41","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41380-018-0058-9","volume":"24","author":"T Pillinger","year":"2019","unstructured":"Pillinger T et al (2019) Is psychosis a multisystem disorder? A meta-review of central nervous system, immune, cardiometabolic, and endocrine alterations in first-episode psychosis and perspective on potential models. Mol Psychiatry 24(6):776\u2013794","journal-title":"Mol Psychiatry"},{"issue":"7","key":"2576_CR42","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1176\/appi.ajp.2016.16040442","volume":"174","author":"AP Rajkumar","year":"2017","unstructured":"Rajkumar AP et al (2017) Endogenous and antipsychotic-related risks for diabetes mellitus in young people with schizophrenia: a Danish population-based cohort study. Am J Psychiatry 174(7):686\u2013694","journal-title":"Am J Psychiatry"},{"key":"2576_CR43","doi-asserted-by":"crossref","unstructured":"Perry BI et al (2021) Longitudinal trends in childhood insulin levels and body mass index and associations with risks of psychosis and depression in young adults. JAMA Psychiatry","DOI":"10.1001\/jamapsychiatry.2020.4180"},{"issue":"6","key":"2576_CR44","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.eurpsy.2009.01.005","volume":"24","author":"M De Hert","year":"2009","unstructured":"De Hert M et al (2009) Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). Eur Psychiatry 24(6):412\u201324","journal-title":"Eur Psychiatry"},{"issue":"5","key":"2576_CR45","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S2215-0366(15)00115-7","volume":"2","author":"DC Henderson","year":"2015","unstructured":"Henderson DC et al (2015) Pathophysiological mechanisms of increased cardiometabolic risk in people with schizophrenia and other severe mental illnesses. Lancet Psychiatry 2(5):452\u2013464","journal-title":"Lancet Psychiatry"},{"issue":"9","key":"2576_CR46","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1080\/00048670903107609","volume":"43","author":"S Verma","year":"2009","unstructured":"Verma S et al (2009) Effect of treatment on weight gain and metabolic abnormalities in patients with first-episode psychosis. Aust N Z J Psychiatry 43(9):812\u20137","journal-title":"Aust N Z J Psychiatry"},{"issue":"3","key":"2576_CR47","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/14740338.2020.1713091","volume":"19","author":"BB Barton","year":"2020","unstructured":"Barton BB et al (2020) Update on weight-gain caused by antipsychotics: a systematic review and meta-analysis. Expert Opin Drug Saf 19(3):295\u2013314","journal-title":"Expert Opin Drug Saf"},{"issue":"9","key":"2576_CR48","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.2337\/db13-0430","volume":"62","author":"KL Teff","year":"2013","unstructured":"Teff KL et al (2013) Antipsychotic-induced insulin resistance and postprandial hormonal dysregulation independent of weight gain or psychiatric disease. Diabetes 62(9):3232\u20133240","journal-title":"Diabetes"},{"key":"2576_CR49","doi-asserted-by":"crossref","unstructured":"O\u2019Donoghue B et al (2020)\u00a0Physical health trajectories of young people commenced on clozapine. Ir J Psychol Med p. 1-7","DOI":"10.1017\/ipm.2020.1"},{"issue":"9896","key":"2576_CR50","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","volume":"382","author":"S Leucht","year":"2013","unstructured":"Leucht S et al (2013) Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. The Lancet 382(9896):951\u2013962","journal-title":"The Lancet"},{"key":"2576_CR51","doi-asserted-by":"crossref","unstructured":"Zhang J-P et al (2013) Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis. Int J Neuropsychopharmacol\u00a016(6): p. 1205-1218","DOI":"10.1017\/S1461145712001277"},{"issue":"1","key":"2576_CR52","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S2215-0366(19)30416-X","volume":"7","author":"T Pillinger","year":"2020","unstructured":"Pillinger T et al (2020) Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis. The Lancet Psychiatry 7(1):64\u201377","journal-title":"The Lancet Psychiatry"},{"issue":"10202","key":"2576_CR53","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(19)31135-3","volume":"394","author":"M Huhn","year":"2019","unstructured":"Huhn M et al (2019) Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis. The Lancet 394(10202):939\u2013951","journal-title":"The Lancet"},{"issue":"2\u20133","key":"2576_CR54","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.schres.2010.07.012","volume":"123","author":"C Rummel-Kluge","year":"2010","unstructured":"Rummel-Kluge C et al (2010) Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis. Schizophr Res 123(2\u20133):225\u201333","journal-title":"Schizophr Res"},{"issue":"12","key":"2576_CR55","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","volume":"353","author":"JA Lieberman","year":"2005","unstructured":"Lieberman JA et al (2005) Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 353(12):1209\u20131223","journal-title":"New England Journal of Medicine"},{"issue":"9618","key":"2576_CR56","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(08)60486-9","volume":"371","author":"RS Kahn","year":"2008","unstructured":"Kahn RS et al (2008) Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. Lancet 371(9618):1085\u201397","journal-title":"Lancet"},{"issue":"8","key":"2576_CR57","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1177\/0269881116645254","volume":"30","author":"SJ Cooper","year":"2016","unstructured":"Cooper SJ et al (2016) BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment. J Psychopharmacol 30(8):717\u201348","journal-title":"J Psychopharmacol"},{"key":"2576_CR58","unstructured":"NICE (2014) National Institute for Health and Clinical Excellence: Guidance, in Psychosis and Schizophrenia in Adults: Treatment and Management: Updated Edition 2014. National Institute for Health and Care Excellence (UK)Copyright (c) National Collaborating Centre for Mental Health,\u00a0London"},{"key":"2576_CR59","unstructured":"Psychiatrists RCo (2014)\u00a0Second National Audit of Schizophrenia. Available from: https:\/\/www.rcpsych.ac.uk\/improving-care\/ccqi\/national-clinical-audits\/national-clinical-audit-of-psychosis\/national-audit-schizophrenia"},{"issue":"6","key":"2576_CR60","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1192\/bjp.bp.113.142521","volume":"205","author":"MJ Crawford","year":"2014","unstructured":"Crawford MJ et al (2014) Assessment and treatment of physical health problems among people with schizophrenia: national cross-sectional study. Br J Psychiatry 205(6):473\u20137","journal-title":"Br J Psychiatry"},{"key":"2576_CR61","unstructured":"Psychiatrists RCo (2012)\u00a0National Audit of Schizophrenia (NAS).\u00a0Available from: https:\/\/www.rcpsych.ac.uk\/improving-care\/ccqi\/national-clinical-audits\/national-clinical-audit-of-psychosis\/national-audit-schizophrenia"},{"issue":"6","key":"2576_CR62","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1192\/bjp.bp.114.152595","volume":"207","author":"D Shiers","year":"2015","unstructured":"Shiers D, Bradshaw T, Campion J (2015) Health inequalities and psychosis: time for action. Br J Psychiatry 207(6):471\u2013473","journal-title":"British Journal of Psychiatry"},{"key":"2576_CR63","volume-title":"Positive Cardiometabolic Health Resource: an intervention framework for patients with psychosis and schizophrenia","author":"D Shiers","year":"2014","unstructured":"Shiers D et al (2014) Positive Cardiometabolic Health Resource: an intervention framework for patients with psychosis and schizophrenia. Royal College of Psychiatrists, London"},{"key":"2576_CR64","unstructured":"Taylor DM, Gaughran F, Pillinger T (2020)\u00a0The Maudsley Practice Guidelines for Physical Health Conditions in Psychiatry"},{"key":"2576_CR65","unstructured":"Psychiatrists RCo (2019)\u00a0National clinical audit of psychosis \u2013 National Report for the Early Intervention in Psychosis Spotlight Audit 2018\/2019.\u00a0Available from: https:\/\/www.rcpsych.ac.uk\/NCAP"},{"key":"2576_CR66","doi-asserted-by":"publisher","first-page":"e97","DOI":"10.1192\/bjo.2019.76","volume":"5","author":"R Pearsall","year":"2019","unstructured":"Pearsall R et al (2019) Health screening, cardiometabolic disease and adverse health outcomes in individuals with severe mental illness. B J Psych open 5:e97. https:\/\/doi.org\/10.1192\/bjo.2019.76","journal-title":"BJPsych open"},{"issue":"9","key":"2576_CR67","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3109\/00048674.2011.595370","volume":"45","author":"A Thompson","year":"2011","unstructured":"Thompson A et al (2011) Targeted intervention to improve monitoring of antipsychotic-induced weight gain and metabolic disturbance in first episode psychosis. Aust N Z J Psychiatry 45(9):740\u20138","journal-title":"Aust N Z J Psychiatry"},{"key":"2576_CR68","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4321\/S0213-61632011000400004","volume":"25","author":"C O'Callaghan","year":"2011","unstructured":"O\u2019Callaghan C et al (2011) Screening for metabolic syndrome in long-term psychiatric illness: audit of patients receiving depot antipsychotic medication at a psychiatry clinic. Eur J Psychiatry 25:213\u2013222","journal-title":"The European Journal of Psychiatry"},{"issue":"3","key":"2576_CR69","doi-asserted-by":"crossref","first-page":"i","DOI":"10.1017\/S079096670001226X","volume":"28","author":"A Murtagh","year":"2011","unstructured":"Murtagh A et al (2011) Improving monitoring for metabolic syndrome using audit. Ir J Psychol Med 28(3):1\u20134","journal-title":"Irish Journal of Psychological Medicine"},{"issue":"10","key":"2576_CR70","doi-asserted-by":"crossref","first-page":"e007633","DOI":"10.1136\/bmjopen-2015-007633","volume":"5","author":"TRE Barnes","year":"2015","unstructured":"Barnes TRE et al (2015) Screening for the metabolic side effects of antipsychotic medication: findings of a 6-year quality improvement programme in the UK. BMJ Open 5(10):e007633","journal-title":"BMJ Open"},{"issue":"2","key":"2576_CR71","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1017\/ipm.2013.5","volume":"30","author":"D Gallagher","year":"2013","unstructured":"Gallagher D et al (2013) A health screening and promotion clinic to improve metabolic monitoring for patients prescribed antipsychotic medication. Ir J Psychol Med 30(2):113\u2013118","journal-title":"Irish Journal of Psychological Medicine"},{"issue":"3","key":"2576_CR72","doi-asserted-by":"crossref","first-page":"e000748","DOI":"10.1136\/bmjoq-2019-000748","volume":"9","author":"S Michael","year":"2020","unstructured":"Michael S, MacDonald K (2020) Improving rates of metabolic monitoring on an inpatient psychiatric ward. BMJ Open Quality 9(3):e000748","journal-title":"BMJ Open Quality"},{"key":"2576_CR73","doi-asserted-by":"crossref","unstructured":"Mouko J, Sullivan R (2017)\u00a0Systems for physical health care for mental health patients in the community: different approaches to improve patient care and safety in an Early Intervention in Psychosis Service. BMJ Qual Improv Rep\u00a06(1)","DOI":"10.1136\/bmjquality.u209141.w3798"},{"key":"2576_CR74","unstructured":"Ireland, H.N.W.G.a.C.A.G.o.C.o.P.o (2019)\u00a0HSE national clinical programme for early intervention in psychosis - model of care. Available from: http:\/\/www.hse.ie\/eng\/about\/Who\/cspd\/ncps\/mental-health\/"},{"issue":"2","key":"2576_CR75","first-page":"115","volume":"7","author":"K Vasudev","year":"2010","unstructured":"Vasudev K, Martindale BV (2010) Physical healthcare of people with severe mental illness: everybody\u2019s business! Ment Health Fam Med 7(2):115\u201322","journal-title":"Ment Health Fam Med"},{"key":"2576_CR76","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1471-244X-12-78","volume":"12","author":"E Bonfioli","year":"2012","unstructured":"Bonfioli E et al (2012) Health promotion lifestyle interventions for weight management in psychosis: a systematic review and meta-analysis of randomised controlled trials. BMC Psychiatry 12:78","journal-title":"BMC Psychiatry"},{"key":"2576_CR77","doi-asserted-by":"crossref","first-page":"113402","DOI":"10.1016\/j.psychres.2020.113402","volume":"293","author":"A Shannon","year":"2020","unstructured":"Shannon A et al (2020) A systematic review of the effectiveness of group-based exercise interventions for individuals with first episode psychosis. Psychiatry Res 293:113402","journal-title":"Psychiatry Res"},{"key":"2576_CR78","doi-asserted-by":"crossref","unstructured":"Fouhy F, Cullen W, O\u2019Connor K (2020)\u00a0Physical health interventions for patients who have experienced a first episode of psychosis: a narrative review. Ir J Psychol Med\u00a0p. 1-14","DOI":"10.1017\/ipm.2020.92"},{"issue":"5","key":"2576_CR79","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/eip.12884","volume":"14","author":"B O'Donoghue","year":"2020","unstructured":"O\u2019Donoghue B et al (2020) Physical health assistance in early recovery of psychosis: study protocol for a randomized controlled trial. Early Interv Psychiatry 14(5):587\u2013593","journal-title":"Early Intervention in Psychiatry"},{"key":"2576_CR80","doi-asserted-by":"crossref","unstructured":"Morrison AP et al (2020)\u00a0Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study. The Lancet Psychiatry","DOI":"10.1016\/S2215-0366(20)30248-0"},{"issue":"4","key":"2576_CR81","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1176\/appi.ajp.2015.15050632","volume":"173","author":"John M Kane","year":"2016","unstructured":"Kane John M et al (2016) Comprehensive versus usual community care for first-episode psychosis: 2-year outcomes from the NIMH RAISE Early Treatment Program. Am J Psychiatry 173(4):362\u2013372","journal-title":"American Journal of Psychiatry"},{"key":"2576_CR82","doi-asserted-by":"crossref","unstructured":"Horowitz MA, Murray RM, Taylor D (2020)\u00a0Tapering antipsychotic treatment. JAMA Psychiatry","DOI":"10.1001\/jamapsychiatry.2020.2166"},{"key":"2576_CR83","doi-asserted-by":"crossref","first-page":"112671","DOI":"10.1016\/j.psychres.2019.112671","volume":"284","author":"T Nguyen","year":"2020","unstructured":"Nguyen T et al (2020) The effect of Clinical Practice Guidelines on prescribing practice in mental health: a systematic review. Psychiatry Res 284:112671","journal-title":"Psychiatry Research"},{"issue":"3","key":"2576_CR84","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1017\/ipm.2014.18","volume":"31","author":"J Kelly","year":"2014","unstructured":"Kelly J et al (2014) The impact of a change in prescribing policy on antipsychotic prescribing in a general adult psychiatric hospital. Ir J Psychol Med 31(3):167\u2013173","journal-title":"Ir J Psychol Med"},{"issue":"4","key":"2576_CR85","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1017\/ipm.2015.1","volume":"32","author":"J Kelly","year":"2015","unstructured":"Kelly J et al (2015) The impact of a change in prescribing policy on antipsychotic prescribing in a general adult psychiatric hospital. Ir J Psychol Med 32(4):361\u2013363","journal-title":"Irish Journal of Psychological Medicine"},{"key":"2576_CR86","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.schres.2019.08.027","volume":"215","author":"T Nguyen","year":"2020","unstructured":"Nguyen T et al (2020) Reduction in the prescription of Olanzapine as a first-line treatment for first episode psychosis following the implementation of clinical practice guidelines. Schizophr Res 215:469\u2013470","journal-title":"Schizophr Res"},{"issue":"1","key":"2576_CR87","doi-asserted-by":"crossref","first-page":"e040387","DOI":"10.1136\/bmjopen-2020-040387","volume":"11","author":"D Keating","year":"2021","unstructured":"Keating D et al (2021) Prescribing pattern of antipsychotic medication for first-episode psychosis: a retrospective cohort study. BMJ Open 11(1):e040387","journal-title":"BMJ Open"},{"key":"2576_CR88","doi-asserted-by":"crossref","unstructured":"American Diabetes Association APA,  Endocrinologists AAoC,  Obesity\u00a0NAAftSo\u00a0(2004)\u00a0Consensus development conference on antipsychotic drugs and obesity and diabetes. Obes Res\u00a012(2): p. 362-368","DOI":"10.1038\/oby.2004.46"},{"issue":"4","key":"2576_CR89","doi-asserted-by":"crossref","first-page":"e0122704","DOI":"10.1371\/journal.pone.0122704","volume":"10","author":"M Sinnott","year":"2015","unstructured":"Sinnott M et al (2015) Fasting plasma glucose as initial screening for diabetes and prediabetes in Irish adults: the Diabetes Mellitus and Vascular Health Initiative (DMVhi). PLoS One 10(4):e0122704","journal-title":"PLOS ONE"},{"key":"2576_CR90","unstructured":"Ireland IoPHi (2010)\u00a0Hypertension briefing.\u00a0Available from: http:\/\/www.publichealth.ie\/sites\/default\/files\/Hypertension%20Briefing%2015%20May%202012%20FINAL.pdf"},{"issue":"7","key":"2576_CR91","doi-asserted-by":"crossref","first-page":"e13115","DOI":"10.2196\/13115","volume":"8","author":"G McCombe","year":"2019","unstructured":"McCombe G et al (2019) Key worker-mediated enhancement of physical health in first episode psychosis: protocol for a feasibility study in primary care. JMIR Res Protoc 8(7):e13115\u2013e13115","journal-title":"JMIR research protocols"},{"key":"2576_CR92","doi-asserted-by":"crossref","unstructured":"Fogarty F et al (2020)\u00a0Physical health among patients with common mental health disorders in primary care in Europe: a scoping review. Ir J Psychol Med\u00a0p. 1-17","DOI":"10.1017\/ipm.2020.2"},{"key":"2576_CR93","unstructured":"Health Df (2013)\u00a0e-Health strategy for Ireland.\u00a0Available from: \nhttps:\/\/www.ehealthireland.ie\/Strategic-Programmes\/Electronic-Health-Record-EHR"},{"issue":"2","key":"2576_CR94","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/schbul\/sbv132","volume":"42","author":"J Firth","year":"2016","unstructured":"Firth J et al (2016) Mobile phone ownership and endorsement of \u201cmHealth\u201d among people with psychosis: a meta-analysis of cross-sectional studies. Schizophr Bull 42(2):448\u2013455","journal-title":"Schizophrenia bulletin"},{"issue":"1","key":"2576_CR95","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/wps.20592","volume":"18","author":"J Torous","year":"2019","unstructured":"Torous J et al (2019) Towards a consensus around standards for smartphone apps and digital mental health. World Psychiatry: Official J World Psychiatr Assoc (WPA) 18(1):97\u201398","journal-title":"World psychiatry : official journal of the World Psychiatric Association (WPA)"},{"issue":"10","key":"2576_CR96","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1176\/appi.ps.201700391","volume":"69","author":"A Muralidharan","year":"2018","unstructured":"Muralidharan A et al (2018) Impact of online weight management with peer coaching on physical activity levels of adults with serious mental illness. Psychiatr Serv 69(10):1062\u20131068","journal-title":"Psychiatr Serv"},{"issue":"4","key":"2576_CR97","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s11126-015-9337-7","volume":"86","author":"C Macias","year":"2015","unstructured":"Macias C et al (2015) Using smartphone apps to promote psychiatric and physical well-being. Psychiatr Q 86(4):505\u201319","journal-title":"Psychiatr Q"},{"key":"2576_CR98","doi-asserted-by":"crossref","unstructured":"Hoffman L et al (2020)\u00a0Digital Opportunities for Outcomes in Recovery Services (DOORS): a pragmatic hands-on group approach toward increasing digital health and smartphone competencies, autonomy, relatedness, and alliance for those with serious mental illness. J Psychiatr Pract 26(2): p. 80-88","DOI":"10.1097\/PRA.0000000000000450"},{"issue":"7","key":"2576_CR99","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1177\/0706743719828977","volume":"64","author":"AN Vaidyam","year":"2019","unstructured":"Vaidyam AN et al (2019) Chatbots and conversational agents in mental health: a review of the psychiatric landscape. Can J Psychiatr 64(7):456\u2013464","journal-title":"The Canadian Journal of Psychiatry"},{"key":"2576_CR100","doi-asserted-by":"crossref","unstructured":"Tr\u00e9hout M et al (2020)\u00a0A web-based adapted physical activity program (e-APA) versus health education program (e-HE) in patients with schizophrenia and healthy volunteers: study protocol for a randomized controlled trial (PEPSY V@Si). Eur Arch Psychiatry Clin Neurosci","DOI":"10.21203\/rs.2.456\/v1"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-021-02576-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-021-02576-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-021-02576-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T07:50:34Z","timestamp":1744185034000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-021-02576-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,8]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["2576"],"URL":"https:\/\/doi.org\/10.1007\/s11845-021-02576-5","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"type":"print","value":"0021-1265"},{"type":"electronic","value":"1863-4362"}],"subject":[],"published":{"date-parts":[[2021,3,8]]},"assertion":[{"value":"18 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committee on human experimentation with the Helsinki Declaration of 1975, as revised in 2008. The SJH\/AMNCH Research Ethics Committee deemed this project an audit, and therefore, there were no ethical issues.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}